Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06494423 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Employment Support After Hematopoietic Stem Cell Transplantation

Study acronym: WorkS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027
    • Site contact updated
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 2025 to Dec 31, 2025
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 2024 to Jul 31, 2024
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.
Trial Details
NCT Number NCT06494423
Lead Sponsor MGH Institute of Health Professions
Collaborators: Massachusetts General Hospital
Conditions
(from sponsor)		 Hematopoietic Stem Cell Transplantation
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov